LLS invested $67.2 million in research in fiscal year 2015 to advance life-saving research. Hear from some of the world’s leading blood cancer researchers about how LLS’s support makes it possible to fund their important discoveries.
Just one of these projects is the LLS Beat AML initiative. AML causes more than 10,000 deaths in the U.S. every year. LLS launched a groundbreaking Beat AML collaboration with Dr. Druker, his team at Oregon Health & Science University's (OHSU) Knight Cancer Institute, and top universities and technology companies to not only change the way AML is treated but to seek out more positive outcomes for patients.
Louis J. DeGennaro, Ph.D, LLS’s president and CEO, and Steven T. Rosen, M.D., provost and chief scientific officer of City of Hope, and chairman of LLS’s Medical and Scientific Advisory Board, discuss LLS’s research funding programs.